Small private meetings with US Food and Drug Administration staff are now more widely used than larger public events to gather first-hand patient information to aid regulatory decisions.
Patient listening sessions (behind-closed-doors gatherings of a small group of patients and advocates to discuss experiences and unmet needs with...